Clene Inc. (CLNN)
NASDAQ: CLNN · Real-Time Price · USD
8.50
+0.25 (3.03%)
At close: Oct 17, 2025, 4:00 PM EDT
8.18
-0.32 (-3.76%)
After-hours: Oct 17, 2025, 7:28 PM EDT
Clene Revenue
Clene had revenue of $27.00K in the quarter ending June 30, 2025, a decrease of -70.33%. This brings the company's revenue in the last twelve months to $286.00K, down -35.29% year-over-year. In the year 2024, Clene had annual revenue of $342.00K, down -47.71%.
Revenue (ttm)
$286.00K
Revenue Growth
-35.29%
P/S Ratio
247.60
Revenue / Employee
$3,763
Employees
76
Market Cap
85.59M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 342.00K | -312.00K | -47.71% |
Dec 31, 2023 | 654.00K | 181.00K | 38.27% |
Dec 31, 2022 | 473.00K | -250.00K | -34.58% |
Dec 31, 2021 | 723.00K | 517.00K | 250.97% |
Dec 31, 2020 | 206.00K | - | - |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Walmart | 693.15B |
Costco Wholesale | 275.24B |
PepsiCo | 91.75B |
The Procter & Gamble Company | 84.28B |
Unilever | 70.19B |
Anheuser-Busch InBev | 58.52B |
The Coca-Cola Company | 47.06B |
Philip Morris International | 39.06B |
CLNN News
- 3 days ago - Clene to Participate in a Panel Discussion at the Maxim Growth Summit - GlobeNewsWire
- 23 days ago - Clene Presents New Clinical Data at ECTRIMS 2025 Meeting Demonstrating CNM-Au8® Improves Brain Energy Metabolism in Multiple Sclerosis Patients - GlobeNewsWire
- 6 weeks ago - Clene Presents Preclinical Data Supporting CNM-Au8® for the Treatment of Parkinson's Disease - GlobeNewsWire
- 6 weeks ago - Clene to Present at the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 2 months ago - Clene Reports Second Quarter 2025 Financial Results and Recent Operating Highlights - GlobeNewsWire
- 2 months ago - Clene to Present at the Emerging Growth Conference - GlobeNewsWire
- 2 months ago - Clene to Present at the Canaccord 45th Annual Growth Conference - GlobeNewsWire
- 3 months ago - Clene Provides Regulatory Update Following Constructive FDA Type-C Meeting on Neurofilament Biomarker Analysis Plan and Confirms Two Additional FDA Meetings - GlobeNewsWire